ArticleRevista peruana de medicina experimental y salud publica2025
New world health organization guideline on anemia cut-off points: implications for children aged 6-35 months in Peru.
Article in Revista peruana de medicina experimental y salud publica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Anemia crisis among children in Peru: a scoping review.Revista panamericana de salud publica = Pan American journal of public health · 2026Review
- Political instability and child anemia in Peru: a national interrupted time-series analysis, 2006-2024.Frontiers in public health · 2026Article
- New world health organization guideline on anemia cut-off points: implications for children aged 6-35 months in Peru.Revista peruana de medicina experimental y salud publica · 2025Article
- Beyond deficiency: The emerging health risks of excess iron.Science progressArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundMotivation for the study. In 2024, the World Health Organization modified the cut-off points that define anemia. The magnitude of the change in the prevalence of anemia in children aged 6-35 months in Peru, compared to the 2001 guideline, is unknown. Main findings. Between 2009 and 2023, we found significant and heterogeneous differences (a) nationally, (b) between and within regions, and (c) depending on the calculation technique (table or equation). Implications. The rationale for the 2024 guideline, while much better than that for the 2001 guideline, is not sufficient. The new guideline should be adopted with caution, both in individual care and population-related decisions. OBJECTIVES.: To compare annual national and regional prevalence rates of anemia, using the 2001 guideline versus the new 2024 guideline in children aged 6 to 35 months residing in Peru between 2009 and 2023. To assess whether differences exist between guidelines vary by region, setting, or year. MATERIALS AND METHODS.: Secondary analysis of the Demographic and Family Health Survey (continuous national random sample, stratified and clustered). Hemoglobin was measured in capillary blood using Hemocue. We applied an equation (and/or table) for altitude adjustment and a cutoff point for each guideline. We calculated 95% confidence intervals [95% CI]. Differences were evaluated according to region, setting, and/or year using a generalized linear model, calculating extremes and quartiles. Estimates and models were weighted. RESULTS.: We analyzed 120,711 children. The difference in prevalence was -6.3 [-6.6 to -6.0], p<0.001, varying by region (p<0.001), region-year (p=0.004), and region-setting (p<0.001), between -40.6 and 11.0. The percentage of children whose diagnosis differed was 11.0 [10.7 to 11.2], (p<0.001), varying between 0.0 and 40.6. The difference between the table and the equation was -3.8 [-4.0 to -3.6]. CONCLUSIONS.: The prevalence differs with the new guideline (generally decreasing, but may increase), with variable differences according to region, setting, and year. The percentage with a different diagnosis also varies. These differences are of great importance for health, in some cases changing the problem from severe to moderate. The table calculation underestimates the equation calculation. Literature supports the direction of the correction, but not its magnitude.
backgroundMotivation for the study. In 2024, the World Health Organization modified the cut-off points that define anemia. The magnitude of the change in the prevalence of anemia in children aged 6-35 months in Peru, compared to the 2001 guideline, is unknown. Main findings. Between 2009 and 2023, we found significant and heterogeneous differences (a) nationally, (b) between and within regions, and (c) depending on the calculation technique (table or equation). Implications. The rationale for the 2024 guideline, while much better than that for the 2001 guideline, is not sufficient. The new guideline should be adopted with caution, both in individual care and population-related decisions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.